These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 227475)

  • 21. Inhibitory effect of fasting on the activation of liver glycogen phosphorylase of rats by arginine-vasopressin.
    Németh S
    Exp Clin Endocrinol; 1983 Jul; 82(1):104-6. PubMed ID: 6311593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Regulation of glycogenolysis against hormones in isolated rat hepatocytes].
    Chen W
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Apr; 15(2):123-7. PubMed ID: 8242820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effect of O-alkylated analogues of oxytocin and vasopressin on human and rat myometrial activity.
    Melin P; Vilhardt H; Lindeberg G; Larsson LE; Akerlund M
    J Endocrinol; 1981 Feb; 88(2):173-80. PubMed ID: 7193709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Excitation of neurones in the rat paraventricular nucleus in vitro by vasopressin and oxytocin.
    Inenaga K; Yamashita H
    J Physiol; 1986 Jan; 370():165-80. PubMed ID: 3007746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of acute hemodynamic effects of antidiuretic agonists in conscious dogs.
    Liard JF
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):174-80. PubMed ID: 2452311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasopressin and angiotensin control the activity of liver phosphodiesterase.
    Keppens S; De Wulf H
    Biochem J; 1984 Aug; 222(1):277-80. PubMed ID: 6089761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of vasopressin and related peptides on glycogen phosphorylase activity and phosphatidylinositol metabolism in hepatocytes.
    Kirk CJ; Rodrigues LM; Hems DA
    Biochem J; 1979 Feb; 178(2):493-6. PubMed ID: 444224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine antagonism does not potentiate the effects of oxytocin and vasopressin on prolactin secretion.
    Pan JT; Mai LM
    Life Sci; 1990; 47(26):2443-50. PubMed ID: 2263168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mode of inhibition of glycogenolysis in rat liver by the dihydropyridine derivative, BAY R3401: inhibition and inactivation of glycogen phosphorylase by an activated metabolite.
    Bergans N; Stalmans W; Goldmann S; Vanstapel F
    Diabetes; 2000 Sep; 49(9):1419-26. PubMed ID: 10969824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antidiuretic and pressor activities of vasopressin analogs with L-alaninamide and D-alaninamide substitutions at position 9.
    Buku A; Gazis D; Schwartz IL
    Int J Pept Protein Res; 1984 May; 23(5):551-7. PubMed ID: 6547408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo apparent peptide-receptor dissociation rate constants for arginine vasopressin analogs estimated from inhibition of rat pressor responses.
    Gazis D
    Can J Physiol Pharmacol; 1987 Oct; 65(10):2099-103. PubMed ID: 2827873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasopressin-induced antinociception: an investigation into its physiological and hormonal basis.
    Berson BS; Berntson GG; Zipf W; Torello MW; Kirk WT
    Endocrinology; 1983 Jul; 113(1):337-43. PubMed ID: 6861706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antagonistic properties of tetra-substituted analog of vasopressin with selective antidiuretic effects].
    Myshliakova NV; Afanas'eva GA; Strazda GM; Papsuevich OS; Klusha NV; Chipens GI
    Biull Eksp Biol Med; 1992 Feb; 113(2):150-2. PubMed ID: 1611060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulation of inorganic-phosphate incorporation into phosphatidylinositol in rat thoracic aorta mediated through V1-vasopressin receptors.
    Takhar AP; Kirk CJ
    Biochem J; 1981 Jan; 194(1):167-72. PubMed ID: 6272723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterologous desensitization of the cyclic AMP-independent glycogenolytic response in rat liver cells.
    Bréant B; Keppens S; De Wulf H
    Biochem J; 1981 Dec; 200(3):509-14. PubMed ID: 6123310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasopressin-stimulated release of atriopeptin: endocrine antagonists in fluid homeostasis.
    Manning PT; Schwartz D; Katsube NC; Holmberg SW; Needleman P
    Science; 1985 Jul; 229(4711):395-7. PubMed ID: 2990050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurohypophyseal peptides and tachykinins stimulate the production of cyclic GMP in cultured porcine aortic endothelial cells.
    Schini VB; Katusic ZS; Vanhoutte PM
    J Pharmacol Exp Ther; 1990 Dec; 255(3):994-1000. PubMed ID: 2175809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel ligand specificity of pituitary vasopressin receptors in the rat.
    Antoni FA
    Neuroendocrinology; 1984 Aug; 39(2):186-8. PubMed ID: 6089020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of vasopressin inhibition of pancreatic secretion.
    Wolfson P; Cort JH; Dreiling DA
    Am J Gastroenterol; 1979 May; 71(5):490-5. PubMed ID: 453143
    [No Abstract]   [Full Text] [Related]  

  • 40. Hypothermia induced by centrally administered vasopressin in rats. A structure-activity study.
    Meisenberg G; Simmons WH
    Neuropharmacology; 1984 Oct; 23(10):1195-200. PubMed ID: 6549207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.